Artikel: Crossroads of Antimicrobial and Diagnostic Stewardship: Assessing Risks to Develop Clinical Decision Support to Combat Multidrug-Resistant
Open forum infectious diseases
2023 Band 10, Heft 10, Seite(n) ofad512
Abstract: Background: Early detection of multidrug-resistant : Methods: This was a mixed-methods study. We conducted a split-sample cohort study of adult critical care patients with : Results: The 2 previous risk prediction tools demonstrated similar ... ...
Abstract | Background: Early detection of multidrug-resistant Methods: This was a mixed-methods study. We conducted a split-sample cohort study of adult critical care patients with Results: The 2 previous risk prediction tools demonstrated similar accuracy in the derivation cohort (c-statistic of 0.76 [95% confidence interval {CI}, .69-.83] and 0.73 [95% CI, .66-.8]). A simplified tool based on 4 variables demonstrated reasonable accuracy (c-statistic of 0.71 [95% CI, .57-.85]) without significant overprescribing in the validation cohort. The risk factors were prior MDRP infection, ≥4 antibiotics prior to culture, infection >3 days after admission, and dialysis. Fourteen clinicians completed the survey. An alert providing context regarding individual patient risk factors for MDRP was preferred. Conclusions: These results can be used to develop a local EMR-integrated tool to improve timeliness of effective therapy in those at risk of MDRP infections. |
---|---|
Sprache | Englisch |
Erscheinungsdatum | 2023-10-12 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article |
ZDB-ID | 2757767-3 |
ISSN | 2328-8957 |
ISSN | 2328-8957 |
DOI | 10.1093/ofid/ofad512 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.